Pairing the milk-derived antimicrobial peptide lactoferricin with an enzyme that disrupts bacterial communication produces synergistic killing effects against bacteria and yeast.
SynergisticHis6-OPH enzyme plus lactoferricin peptide killed microorganisms more effectively than either agent alone, while the peptide also boosted the enzyme's catalytic efficiency
What the researchers found
Combining the milk-derived antimicrobial peptide lactoferricin (Lfcin) with an enzyme that disrupts bacterial communication (His6-OPH, a quorum quenching enzyme) produced synergistic antimicrobial effects against bacteria and yeasts. The enzyme-peptide combination killed microorganisms more effectively than the peptide alone. Additionally, Lfcin stabilized the enzyme's activity and increased its catalytic efficiency for breaking down bacterial signaling molecules (quorum sensing lactones).
Molecular docking simulations first predicted which peptide-enzyme pairings would work best, and experimental testing confirmed that His6-OPH/Lfcin was the optimal combination among three lactoferrin-derived peptides and two enzymes tested.
Why it matters
Bacteria develop resistance partly through quorum sensing — a communication system that coordinates collective behaviors like biofilm formation and toxin production. By combining a peptide that kills bacteria directly with an enzyme that disrupts their communication, this dual approach attacks pathogens on two fronts simultaneously, making resistance development much harder. This 'peptide + enzyme' strategy represents a novel paradigm for fighting drug-resistant infections.
The numbers in context
3 lactoferrin-derived peptides tested · 2 quorum quenching enzymes · His6-OPH/Lfcin selected as best combination · Improved antimicrobial activity vs Lfcin alone · Enhanced catalytic efficiency for lactone hydrolysis
How the study worked
In silico molecular docking first screened combinations of three lactoferrin-derived peptides (lactoferricin, lactoferampin, Lf(1-11)) with two quorum quenching enzymes (His6-OPH and penicillin acylase). The His6-OPH/Lfcin combination was selected for experimental validation. Physical-chemical characterization assessed enzyme stability. Antimicrobial activity was tested against bacteria and yeasts using the combination versus peptide alone.
Who was studied
In vitro testing against various bacteria and yeasts (specific strains not detailed in abstract)
What this study cannot tell us
All results are in vitro — no animal or clinical testing was performed. The specific bacterial and yeast strains tested are not detailed in the abstract. The practical delivery mechanism for an enzyme-peptide combination (stability, shelf life, formulation) is not addressed. Whether the synergy holds against drug-resistant clinical isolates and biofilms in real-world conditions remains unknown.
How to read the evidence
This is an early-stage in vitro study combining computational docking with experimental antimicrobial testing. It demonstrates proof of concept for the peptide-enzyme combination but is far from clinical relevance.
When this study was published
Published in 2023. The peptide-enzyme antimicrobial combination approach is a relatively new and active area of research in the fight against antibiotic resistance.
The bigger picture
The antimicrobial resistance crisis requires not just new drugs but new strategies. Combining antimicrobial peptides with quorum quenching enzymes is a 'disrupt and destroy' approach — silencing bacterial coordination while simultaneously killing them. Lactoferricin comes from a safe, natural source (milk), and quorum quenching enzymes are non-toxic to human cells. If this concept can be developed into a practical formulation, it could provide a new weapon against biofilm-forming, drug-resistant infections.
Questions still open
- Can this peptide-enzyme combination penetrate established biofilms, where drug-resistant bacteria are most difficult to treat?
- How would this combination be formulated for clinical use — as a topical wound treatment, injectable, or something else?
- Would the synergistic effect hold against clinical multidrug-resistant isolates like MRSA or carbapenem-resistant Enterobacteriaceae?
Common questions
What is quorum sensing and why does disrupting it help fight infections?
What is lactoferricin?
Read the original research
Synergistic Antimicrobial Action of Lactoferrin-Derived Peptides and Quorum Quenching Enzymes.
International journal of molecular sciences, 24(4)
Citation
Aslanli, Aysel; Domnin, Maksim; Stepanov, Nikolay; Efremenko, Elena. (2023). Synergistic Antimicrobial Action of Lactoferrin-Derived Peptides and Quorum Quenching Enzymes.. International journal of molecular sciences, 24(4). https://doi.org/10.3390/ijms24043566